Search

Gene therapy based on small interfering RNA (siRNA) has emerged as an exciting new therapeutic approach. In this work, incorporation of PEI into poly(d,l-lactide-co-glycolide)-poly(ethylene glycol) (PLGA-b-PEG) particles has been shown to be quite effective in the development of corresponding gene delivery systems, and encapsulation of magnetic nanoparticles as an MRI contrast agent, resulted in unique theranostic nanoparticles.

Monodisperse, colloidal silica nanoparticles (NPs) are being widely investigated due to a variety of applications in various fields of chemistry. Many works utilize incorporation of various functional groups to silica NPs for their further modifications. However, at present no benzophenone (BPh) or phenyl azide (PA) containing silica NPs exist. Upon UV irradiation BPh and PA form highly reactive species that react with any organic material. Here we present a convenient method for the preparation of novel hybrid photoreactive silica NPs (denoted as SiO2@photoreactive group) prepared by co-condensation of photoreactive organosilanes and tetraethyl orthosilicate (TEOS) to obtain SiO2@PA and SiO2@BPh NPs. The reactivity of these two types of silica NPs is compared to that of perfluorinated phenyl azide (PFPA) based SiO2 NPs. The reactivity evaluation is carried out by the reaction of the three types of SiO2 NPs with highly inert poly(2-chloro-paraxylelene) films. It is found that, in contrast to what is stated in the literature, PA is much more reactive than PFPA, when dealing with solid state photochemical reactions. Next, photoreactive silica NPs on polymer films are used as an intermediate functional phase for a second modification step using silane-based chemistry. A successful incorporation of amine functionality onto silica NPs is achieved by their reaction with 3-aminopropyltriethoxysilane (APTES) and is verified by fluorescence microscopy. This strategy provides a general and versatile route to efficient functionalization of silica by light.